-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOFRONTERA SUBMITS SUPPLEMENTAL NEW DRUG APPLICATION TO FDA TO EXPAND AMELUZ® RED LIGHT PDT TO ACTINIC KERATOSES ON THE FULL BODY

Reuters·10/08/2026 13:22:00

Please log in to view news